Clinical trials
Completed Glucose Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
226 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 11 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 10 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 10 |
| 2014 | 13 |
| 2015 | 10 |
| 2016 | 16 |
| 2017 | 19 |
| 2018 | 18 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 15 |
| 2024 | 8 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 226 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 33 |
| Eli Lilly and Company | 8 |
| University Hospital, Gentofte, Copenhagen | 8 |
| AstraZeneca | 5 |
| Maastricht University Medical Center | 5 |
| Merck Sharp & Dohme LLC | 5 |
| Pfizer | 5 |
| University of Aarhus | 5 |
| Steno Diabetes Center Copenhagen | 4 |
| Ultragenyx Pharmaceutical Inc | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 226 |
| Diabetes Mellitus | 106 |
| Diabetes Mellitus, Type 2 | 84 |
| Metabolic Diseases | 76 |
| Endocrine System Diseases | 61 |
| Dyslipidemias | 37 |
| Insulin Resistance | 32 |
| Diabetes Mellitus, Type 1 | 25 |
| Diabetes Mellitus, Lipoatrophic | 19 |
| Autoimmune Diseases | 15 |
Trials
Showing 76 to 100 of 226. Each trial links to its page on Pharma Observatory.
126 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.